Xilio Therapeutics, Inc.XLONASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 3Y Ago
-1.3x
Contraction
Streak
4 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -20.95% |
| 2023 | -11.93% |
| 2022 | 15.65% |
| 2021 | 16.57% |
| 2020 | 208.01% |
| 2019 | 0.00% |